However, existing data on the role of tumour-associated B cells (TAB) indicate a tumour promoting function in solid tumour where their immunoinhibitory function resembles that of regulatory B cells (B-regs), which increase in tumour progression and are a proven source of inhibitory cytokines such as IL-10 and TGF-β [67]. The gene discussed is TGFB1; the disease is neoplasm.